v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash $ 1,375,014 $ 148,284
Marketable Securities 14,002,767
Prepaid expenses 569,825 1,218
Total Current Assets 15,947,606 149,502
Non-Current Assets    
Operating Lease Right-of-Use Asset 64,231 527,195
Goodwill 10,498,539
Investment in Oravax, Inc. 1,500,000
Total Non-Current Assets 12,062,770 527,195
Total Assets 28,010,376 676,697
Current Liabilities    
Trade and Other Payables 2,053,542 1,801,729
Notes Payable 1,200,000
Operating Lease Liability 38,932 481,049
PPP Loan Payable 70,600
Total Current Liabilities 2,092,474 3,553,378
Non-Current Liabilities    
Line of Credit Payable – Related Party, net of discount 2,333,984
Operating Lease Liability, net of current portion 25,978 46,369
Total Non-Current Liabilities 25,978 2,380,353
Total Liabilities 2,118,452 5,933,731
Commitments and Contingencies  
STOCKHOLDERS’ EQUITY    
Preferred stock, value
Common stock, value 4,004
Additional Paid in Capital 43,411,487
Accumulated Deficit (75,321,846) (48,672,525)
Total Stockholders’ Equity (Deficit) 25,891,924 (5,257,034)
Total Liabilities and Stockholders’ Equity (Deficit) 28,010,376 676,697
Series C Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock, value
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock, value 144,524
Series E Junior Participating Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock, value
Common stock No Par Value [Member]    
STOCKHOLDERS’ EQUITY    
Common stock, value 101,069,246
Common stock Par Value [Member]    
STOCKHOLDERS’ EQUITY    
Common stock, value $ 4,004

Source